The Great Reallocation, the future of financial capitalism in Europe - Webinar 7 July 2021
ฝัง
- เผยแพร่เมื่อ 12 ม.ค. 2025
- There is enough money, but we are not using it right. A growing part of global wealth (including pension savings and private investments) is invested in stocks, financial derivatives and real estate via anonymous markets, the sole motive being short-term returns. At the same time, Europe faces many urgent challenges for the coming post-Covid period. We don’t need a Great Reset, but a Great Reallocation. Change becomes concrete when and because resources are invested differently. The most pressing challenge is therefore: how can we ensure that productive investments (wealth, capital) are allocated to organizations and companies that can contribute to real economy and the common good (climate, inequality, innovation, infrastructure etc.)? And most importantly, who can and should take the lead: governments, business, financial institutions?
In September 2020 the French Institut Montaigne & Comité Médicis published the report “Responsible Capitalism, an opportunity for Europe” with concrete suggestions for lifting financial and regulatory obstacles that are in the way of a distinct European capitalism. Stanislas Pottier (author of the report and advisor to the management of Amundi) presents the highlights of the report in this webinar.
In the fall of 2021 Jan Peter Balkenende, the former prime minister of the Netherlands, will publish his encompassing study on the Future of the Market Economy in Europe. This webinar is used as input to the report.
--------------------------------------------------------------------------------------------------------------------
Webinar 7 July 2021
Moderator: Jan Peter Balkenende
Guests: Stanislas Pottier (Amundi/Comité Médicis), Nora Neuteboom (ABN AMRO), Bert Colijn (ING)
Studio: Pakhuis de Zwijger, Amsterdam
This webinar is produced by Socires and the Sustainable Finance Lab, in cooperation with the Goldschmeding Chair at Vrije Universiteit Amsterdam, the Moral Markets research program at Vrije Universiteit Amsterdam, the Konrad Adenauer Stiftung in Brussels and Berlin, the Institut Montaigne, Comité Médicis and the Goldschmeding Foundation.
